IMS Health Holdings Inc

IMS Health — Q1 2014 Earnings Presentation

30 slides from IMS Health's earnings presentation, May 1, 2014

  1. Slide 1: IMS Health Q1 2014 Earnings Call

    IMS Health Q1 2014 Earnings Call May 1, 2014 IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q1 2014 earnings call Safe Harbor Statement This presentation includes “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation g Reform Act of 1995, including g statements

  3. Slide 3: Financial Performance

    Financial Performance $M, 2010 - 2013 Revenue EBITDA 6% CAGR 11% CAGR @ CFx @ CFx $2,544 $829 $2,162 $620 2010 2013 2010 2013 Dollars are actual foreign exchange rates. EBITDA is “Adjusted EBITDA” as defined in the IMS Health financial statements. CFx is constant currency. IMS Health Confidential. D

  4. Slide 4: Margins

    Margins Rolling 4Qs SG&A % Revenue EBITDA % Revenue 33% 31% 29% 27% 25% 23% 21% 2010 2011 2012 2013 SG&A expense includes: Sales, Sales marketing marketing, administration, administration IT & infrastructure & non capitalized software development. development Revenue does not reflect deferred revenu

  5. Slide 5: Operational Transformation

    Operational Transformation 9,500 7,100 5,200 7,600 Exits Hires 2010 • Delayering • Global COEs Dec. 2013 • Skills upgrade • Technology skills • Process automation • Acquisitions • Customer facing • Emerging markets IMS Health Confidential. Do not distribute outside your organization. 5 (c) 2014 IMS

  6. Slide 6: Growth Strategy: Offerings

    Growth Strategy $M, 2010 – 2013 Revenue Offerings CAGR $2,544 $2,162 +13% $1,019 @ CFx Technology Services $714 +2% Information $1,448 @ CFx $1,525 2010 2013 Dollars are actual foreign exchange rates. CFx is constant currency. IMS Health Confidential. Do not distribute outside your organization. 6 (

  7. Slide 7: Growth Strategy: Geography

    Growth Strategy $M, 2010 – 2013 Revenue Geography CAGR $2,544 $2,162 $440 +11% Emerging Markets $331 @ CFx +5% Developed Markets $1,831 @ CFx $2,104 2010 2013 Dollars are actual foreign exchange rates. CFx is constant currency. IMS Health Confidential. Do not distribute outside your organization. 7

  8. Slide 8: 1st Quarter Results

    1st Quarter Results $M Revenue EBITDA +6.6% +9.5% @ CFx @ CFx $645 $613 $217 $203 Q1 2013 Q1 2014 Q1 2013 Q1 2014 Dollars are actual foreign exchange rates. EBITDA is “Adjusted EBITDA” as defined in the IMS Health financial statements. CFx is constant currency. IMS Health Confidential. Do not distri

  9. Slide 9: 1st Quarter Revenue by Offering

    1st Quarter Revenue Offering 1st Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency I f Information i $382 $378 1 0% 1.0% 2 8% 2.8% Technology $263 $235 11.9% 12.5% Services T t l Total $645 $613 5 2% 5.2% 6 6% 6.6% IMS Health Confidential. Do not distribute outside your organization.

  10. Slide 10: 1st Quarter Revenue by Geography

    1st Quarter Revenue Geography 1st Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency D Developed l d Markets M k t $532 $511 4 2% 4.2% 5 0% 5.0% Emerging Markets $113 $102 10.4% 14.7% T t l Total $645 $613 5 2% 5.2% 6 6% 6.6% IMS Health Confidential. Do not distribute outside your org

  11. Slide 11: 1st Quarter EBITDA

    1st Quarter EBITDA 1st Quarter Versus Prior Year Constant $M 2014 2013 Reported Currency Adjusted EBITDA $217 $203 7.2% 9.5% Adjusted EBITDA 33.7% 33.1% 60 bps 90 bps margin IMS Health Confidential. Do not distribute outside your organization. 11 (c) 2014 IMS Health Incorporated. All Rights Reserved

  12. Slide 12: 1st Quarter P&L

    1st Quarter P&L $M (except per share data) 2014 2013 Operating Income $67 $79 Net (Loss) / Income $(24) $12 Adjusted Net Income $70 $76 Diluted (Loss) / Earnings per Share $(0.09) $0.04 Diluted Adjusted EPS $0 24 $0.24 $0 26 $0.26 IMS Health Confidential. Do not distribute outside your organization.

  13. Slide 13: 1st Quarter Balance Sheet Items & Metrics

    1st Quarter Balance Sheet Items & Metrics $M 2014 2013 Cash & Cash Equivalents & Short Term $544 $729 1 Investments G Gross D Debt bt 2 $5 027 $5,027 $5,027 $5 027 1 Net Debt $4,483 $4,298 1 Cash Used in Operating Activities $(103) $(16) Unlevered Free Cash Flow $(11) $57 Capital Expenditures $(54)

  14. Slide 14: IPO Summary

    IPO Summary • April 4th IMS Health stock (IMS) started trading on the NYSE • 65 million offered at $20.00 per share • 52 million primary shares sold by IMS Health • 13 million secondary shares sold by selling shareholders • 9.75 million additional secondary shares purchased by underwriters (15% unde

  15. Slide 15: IPO Proceeds - Estimated Sources and Uses

    IPO Proceeds - Estimated Sources and Uses $M SOURCES USES IPO Proceeds 1,040 Retire 12.5% Senior Notes 1,136 Term Loan A 500 Retire 7.375 Senior PIK Notes 765 Cash 400 IPO & Debt Fees 1 82 Revolver 148 Other 2 105 Total Sources 2,088 Total Uses 2,088 1. $24M paid in Q1. 2. Other includes: $72M one-t

  16. Slide 16: IPO Pro Forma Gross Leverage Ratio

    IPO Pro Forma Gross Leverage Ratio $M * Gross debt excludes unamortized OID. IMS Health Confidential. Do not distribute outside your organization. 16 (c) 2014 IMS Health Incorporated. All Rights Reserved.

  17. Slide 17: Interest Expense Reduction

    Interest Expense Pro forma annualized - $M 356 ~50% Reduction 169 PRE-IPO POST-IPO* Non Cash Cash * Post-IPO interest expense is based on the pro forma capitalization on the prior slide. IMS Health Confidential. Do not distribute outside your organization. 17 (c) 2014 IMS Health Incorporated. All Ri

  18. Slide 18: Pro Forma Debt Maturity

    Pro Forma Debt Maturity $M 3,000 2,500 Term Loan 2 000 2,000 B EUR 1,500 Term 1,000 Loan B Revolver USD 500 6% --Term Loan A & Term Loan B Amortization-- Term Notes Loan A 0 2014 2015 2016 2017 2018 2019 2020 2021 IMS Health Confidential. Do not distribute outside your organization. 18 (c) 2014 IMS

  19. Slide 19: 2014 Full-Year Guidance

    2014 Full-Year Guidance 2014 VPY% Revenue 5 - 6% Adjusted EBITDA 7.5 - 9.0% Adjusted Net Income 15 – 20% Unlevered FCF/Adj. EBITDA * 80% * Excludes India Building Purchase IMS Health Confidential. Do not distribute outside your organization. 19 (c) 2014 IMS Health Incorporated. All Rights Reserved.

  20. Slide 20: Q&A

    Q&A IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.

  21. Slide 21: Appendix: Non-GAAP Financial Measures

    Appendix: Non-GAAP Financial Measures IMS Health Confidential. (c) 2014 IMS Health Incorporated. All Rights Reserved.

  22. Slide 22: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA 1st Quarter 1st Quarter $M 2014 2013 Net (Loss) Income $(24) $12 (Benefit from) provision for income taxes (13) 5 Other loss (income), net * 17 (16) Interest expense 89 79 Interest income (2) (1) Depreciation and amortization 107 105 Deferred revenue purchase accounting

  23. Slide 23: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA 2009 -2010 2009 2010 $M F ll Year Full Y Q1 Q2 Q3 Q4 F ll Year Full Y Net (Loss) Income $260 $(106) $22 $(78) $(41) $(202) (Benefit from) provision for (24) (56) 13 (68) (2) (113) income taxes Other loss (income), net * 1 71 (77) 98 (48) 44 Interest expense 36 30 75 77

  24. Slide 24: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA 2011 2011 $M Q1 Q2 Q3 Q4 Full Year Net (Loss) Income $(64) $(32) $43 $164 $111 (Benefit from) provision for income (18) (26) 13 (142) (173) taxes Other loss (income), net * 66 32 (48) (42) 7 Interest expense 65 73 73 65 276 Interest income - - (1) - (2) Depreciation and

  25. Slide 25: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA 2012 2012 $M Q1 Q2 Q3 Q4 Full Year Net (Loss) Income $28 $(21) $4 $(53) $(42) (Benefit from) provision for income (64) 74 (37) 7 (19) taxes Other loss (income), net * 31 (74) 36 35 29 Interest expense 68 64 64 79 275 Interest income - - (1) (2) (3) Depreciation and amor

  26. Slide 26: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA 2013 2013 $M Q1 Q2 Q3 Q4 Full Year Net (Loss) Income $12 $8 $(20) $82 $82 (Benefit from) provision for income 5 9 (20) (124) (130) taxes Other loss (income), net * (16) 6 54 30 74 Interest expense 79 75 87 92 333 Interest income (1) (2) (1) (2) (5) Depreciation and amor

  27. Slide 27: Net Income to Adjusted Net Income & Per Share Data

    Net Income to Adjusted Net Income & Per Share Data 1st Quarter $M (except per share data) 2014 2013 Net (Loss) Income $(24) $12 ((Benefit from)) p provision for income taxes ((13)) 5 Amortization associated with purchase accounting 76 75 Deferred revenue purchase accounting adjustments 2 1 Non-cash

  28. Slide 28: Gross Leverage Ratio

    Gross Leverage Ratio 1st Quarter 1st Quarter $M as of March 31, 2014 Gross Debt as of March 31, 2014 $5,027 Adjusted EBITDA for the year ended December 31, 2013(1) 829 Less: Adjusted EBITDA for the three months ended March 31, 2013 (203) Add: Adjusted EBITDA for the three months ended March 31, 2014

  29. Slide 29: Unlevered Free Cash Flow Reconciliation

    Unlevered Free Cash Flow Reconciliation 1st Quarter 1st Quarter $M 2014 2013 Net Cash Used by Operating Activities $(103) $(16) Capital expenditures (33) (7) Additions to computer software (21) (14) Free Cash Flow $(157) $(37) Cash interest payments 102 67 Cash tax payments 29 19 Acquisition related

  30. Slide 30: END

    END IMS Health Confidential. Do not distribute outside your organization. 30 (c) 2014 IMS Health Incorporated. All Rights Reserved.

IMS Health — Q1 2014 Earnings Presentation on 6ix